Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Acquisition

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · · 3 pages · English

Release

This is to inform you that the Board of Directors of the Company have approved to incorporate a limited liability company in Poland as a wholly-owned subsidiary. Details required vide SEBI circular dated 13-July-2023 are given in the annexure.

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases